Basel Medical Group Ltd Ordinary Shares
Basel Medical Group Ltd Ordinary Shares (BMGL) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
bmgl · pe ratio · data through Jun 30, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Basel Medical Group Ltd Ordinary Shares (BMGL) measures how much investors pay for each dollar of the company's trailing earnings. BMGL's current PE ratio of N/A is calculated by dividing its stock price of $0.59 by its TTM earnings per share of $0.00.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-06-30
PE Ratio History
2022 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 3 fiscal years · Front-end computedMinQ1 · 25%58.5x
MedianQ3 · 75%63.1x
Max
At N/A, BMGL's current P/E is lower than in 0% of its annual fiscal year readings over the past 3 years — historically low.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Medical - Healthcare Plans · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Basel Medical Group Ltd Ordinary SharesYou BMGL | $11M | N/A | — | $0.00 |
 iBio, Inc. IBIO | $27M | N/A | — | -$1.75 |
 Intensity Therapeutics, Inc. INTS | $7M | N/A | — | -$0.86 |
 Iterum Therapeutics plc ITRM | $2M | N/A | — | -$1.26 |
 Longduoduo Company Limited LDDD | $28M | 325.23x | — | $0.02 |
 Modular Medical, Inc. MODD | $10M | N/A | — | -$15.26 |
 Nutriband Inc. NTRB | $43M | N/A | — | -$0.71 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-06-30Latest FY2025 | — | $0.00 | — | |
2024-06-30 FY2024 | 54.43x | $0.11 | -13.8% | |
2023-06-30 FY2023 | 63.13x | $0.10 | +8.0% | |
2022-06-30 FY2022 | 58.47x | $0.11 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Basel Medical Group Ltd Ordinary Shares (BMGL) measures how much investors pay for each dollar of the company's trailing earnings. BMGL's current PE ratio of N/A is calculated by dividing its stock price of $0.59 by its TTM earnings per share of $0.00.
Frequently asked questions
BMGL pe ratio · 6 questionsBMGL's current PE ratio is N/A as of 2026-06-08, based on a stock price of $0.59 and TTM EPS of $0.00. Data sourced from Financial Modeling Prep via BMGL's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Basel Medical Group Ltd Ordinary Shares SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08